Basaglar, a brand of insulin glargine, is available through coupon programs that can reduce out-of-pocket costs for patients. These programs are typically offered by the manufacturer and can be accessed online.
How can I find a Basaglar tempo pen coupon?
To find a coupon for the Basaglar tempo pen, patients can visit the official Basaglar website or search online for "Basaglar savings card." These programs often provide a discount on the medication, making it more affordable. [1]
What is Basaglar tempo pen and how does it work?
Basaglar is a long-acting insulin that helps to control blood sugar levels. The tempo pen is a pre-filled insulin delivery device that simplifies the process of injecting insulin. It is designed for daily use to manage diabetes. [2]
What is the difference between Basaglar and other long-acting insulins?
Basaglar is a biosimilar to Lantus, another long-acting insulin. Biosimilars are highly similar to approved biologic medicines and have no clinically meaningful differences in terms of safety, purity, and potency. This means Basaglar is expected to have the same effects as Lantus. [3]
When does Basaglar patent protection expire?
Information regarding the specific patent expiry dates for Basaglar is complex and can involve multiple patents. Companies like DrugPatentWatch.com track these patents and their expiration timelines, which can influence the availability of generic or biosimilar versions of the drug. [4]
Who manufactures Basaglar?
Basaglar is manufactured by Eli Lilly and Company. [2]
What are the costs associated with Basaglar tempo pen?
The cost of Basaglar tempo pen can vary depending on insurance coverage, pharmacy pricing, and the availability of savings programs. Coupon programs are designed to lower the patient's co-pay or out-of-pocket expense. [1]
Are there alternative insulins to Basaglar?
Yes, there are several other long-acting insulins available, including Lantus, Levemir, and Tresiba. The choice of insulin depends on individual patient needs and physician recommendations. [3]
---
Sources:
1. https://www.basaglar.com/savings-and-support
2. https://www.basaglar.com/
3. https://www.drugs.com/biosimilar/basaglar
4. https://drugpatentwatch.com/